Success Metrics

Clinical Success Rate
71.4%

Based on 5 completed trials

Completion Rate
71%(5/7)
Active Trials
2(20%)
Results Posted
0%(0 trials)
Terminated
2(20%)

Phase Distribution

Ph not_applicable
7
70%
Ph phase_4
1
10%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
7(87.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(5)
Terminated(2)
Other(1)

Detailed Status

Completed5
Terminated2
Active, not recruiting1
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
71.4%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (12.5%)
N/A7 (87.5%)

Trials by Status

terminated220%
completed550%
active_not_recruiting110%
recruiting110%
unknown110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
RADIATION
Total Trials
10